Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hematological Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00047021
What this trial is testing

Combination Chemotherapy in Treating Patients With Recurrent or Refractory Leukemia or Lymphoma

Who this might be right for
LeukemiaLymphoma
Case Comprehensive Cancer Center 3
Not applicableUnknownNCT04280133
What this trial is testing

CAR T-CELL Therapy Educational Video Trial

Who this might be right for
Hematologic MalignancyCAR-T Cell Therapy
Massachusetts General Hospital 80
Testing effectiveness (Phase 2)Looking for participantsNCT05745714
What this trial is testing

HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies

Who this might be right for
Acute Lymphoblastic Leukemia, in RelapseLymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) RecurrentLymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent+2 more
Princess Maxima Center for Pediatric Oncology
Not applicableStudy completedNCT05212233
What this trial is testing

Financial Difficulty in Patients With Blood Cancer

Who this might be right for
Chronic Lymphocytic LeukemiaMultiple Myeloma
UNC Lineberger Comprehensive Cancer Center 218
Not applicableStudy completedNCT03301493
What this trial is testing

Genomic Testing and Resulting Medical Decisions

Who this might be right for
Cancer of Unknown OriginCancer RefractoryCancer of Stomach+12 more
Arbeitsgemeinschaft medikamentoese Tumortherapie 1,500
Not applicableUnknownNCT04743544
What this trial is testing

Influence of CYP2C19 Genotype on Safety and Efficacy of Voriconazole in Pediatric Patients With Hematologic Malignancy

Who this might be right for
Adverse Drug Reactions
Dokuz Eylul University 62
Not applicableNot Yet RecruitingNCT07825714
What this trial is testing

Metagenomic Sequencing Across the Infectious Disease Risk and Care Continuum

Who this might be right for
Infectious DiseasesImmunocompromised HostOpportunistic Infections
Karius, Inc. 10,000
Not applicableLooking for participantsNCT03016806
What this trial is testing

Umbilical Cord Blood Transplantation From Unrelated Donors

Who this might be right for
Acute LeukemiaImmune Deficiency DisorderCongenital Hematological Disorder+7 more
University of Rochester 30
Testing effectiveness (Phase 2)Ended earlyNCT00589602
What this trial is testing

T-Cell Depletion, Donor Hematopoietic Stem Cell Transplant (HSCT), and T-Cell Infusions in Treating Patients With Hematologic Cancer or Other Diseases

Who this might be right for
Chronic Myeloproliferative DisordersLeukemiaLymphoma+4 more
The Cleveland Clinic 13
Testing effectiveness (Phase 2)Study completedNCT00606307
What this trial is testing

Phase IIA Study of the HDAC Inhibitor ITF2357 in Patients With JAK-2 V617F Positive Chronic Myeloproliferative Diseases

Who this might be right for
Myeloproliferative Diseases
Italfarmaco 29
Not applicableUnknownNCT04888195
What this trial is testing

Symptom Clusters in Hong Kong Chinese Children With Blood Cancer

Who this might be right for
Child
The Hong Kong Polytechnic University 120
Early research (Phase 1)Study completedNCT00389428
What this trial is testing

Multicenter Study of CPX-351(Cytarabine:Daunorubicin) Liposome Injection in Patients With Advanced Hematologic Cancer.

Who this might be right for
Hematologic Neoplasms
Jazz Pharmaceuticals 48
Early research (Phase 1)UnknownNCT05610202
What this trial is testing

Tolerability and Pharmacokinetics Study of TQB3702 Tablets in Hematologic Tumor Subjects

Who this might be right for
Hematologic Malignancy
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. 137
Early research (Phase 1)Study completedNCT00867230
What this trial is testing

FTS Study in Patients With Advanced Hematologic Malignancies

Who this might be right for
Myelodysplastic SyndromeLeukemia
M.D. Anderson Cancer Center 18
Post-approval studies (Phase 4)Study completedNCT02372357
What this trial is testing

A New Dosing Regimen for Posaconazole Prophylaxis in Children Based on Body Surface Area

Who this might be right for
Hematological Malignancy
Universitaire Ziekenhuizen KU Leuven 14
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07524530
What this trial is testing

Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers

Who this might be right for
Core Binding Factor Alpha SubunitsHematologic NeoplasmsLeukemia+1 more
National Cancer Institute (NCI) 102
Early research (Phase 1)Study completedNCT00004065
What this trial is testing

Chemotherapy in Treating Patients With Refractory Advanced Solid Tumors or Hematologic Cancer

Who this might be right for
Bladder CancerBreast CancerColorectal Cancer+9 more
Memorial Sloan Kettering Cancer Center
Very early researchUnknownNCT05252572
What this trial is testing

Clinical Study of CLL1 CAR-T Cells in the Treatment of Hematological Malignancies

Who this might be right for
AML
Zhejiang University 36
Early research (Phase 1)Study completedNCT00006239
What this trial is testing

Phenylbutyrate and Tretinoin in Treating Patients With Hematologic Cancer

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Diseases
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Not applicableStudy completedNCT04710212
What this trial is testing

Screening for Colonization With Resistant Enterobacterales in Neutropenic Patients With Hematologic Malignancies

Who this might be right for
Hematologic MalignancyLeukemia, AcuteNeutropenia+1 more
Duke University 168
Next Page
26